Targeted Therapies and Small Molecule Inhibitors

Targeted therapies and small molecule inhibitors are transforming cancer treatment by selectively attacking cancer cells while sparing healthy tissues. These therapies work by interfering with specific molecules involved in cancer growth and progression, such as tyrosine kinases and growth factor receptors. By focusing on molecular pathways unique to cancer cells, targeted therapies reduce systemic toxicity and improve treatment efficacy. Emerging small molecule inhibitors, often used in combination with other treatments, address resistance mechanisms and enhance therapeutic responses, offering hope for improved patient outcomes.